Torrent Pharma shares shed 15% on poor Q3 show; global brokerage downgrades stock Dayanand Saini | January 28, 2022 | Stocks News | No Comments Margin should recover in the two quarters, driven by price hikes in India and Brazil adding that India outlook remains strong, which keeps us constructive on the stock, CLSA said Related Posts TML-D Consolidated September 2021 Net Sales at Rs 61,378.82 crore, up 14.66% Y-o-Y No Comments | Nov 2, 2021 BHEL share price plunges 18% post Q4 earnings; brokerages maintain #39;sell#39; No Comments | Jun 15, 2021 Momentum likely to shift to pharma, midcap indices in coming week: Pritesh Mehta of YES Securities No Comments | Feb 7, 2021 Technical View: Nifty forms bullish candle again, rally may extend to 14,900 No Comments | Jan 21, 2021 About The Author Dayanand Saini